卵巢癌、子宫癌和阴道癌：筛查、治疗概述和预后。
Ovarian, Uterine, and Vulvovaginal Cancers: Screening, Treatment Overview, and Prognosis.
机构信息
Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
出版信息
Med Clin North Am. 2023 Mar;107(2):329-355. doi: 10.1016/j.mcna.2022.10.016. Epub 2023 Jan 2.
Ovarian, uterine, and vulvovaginal cancers affect approximately 96,000 women per year in the United States, resulting in approximately 29,000 deaths annually. Routine screening protocols do not detect these malignancies; thus, the recognition of risk factors and evaluation of worrisome symptoms are essential for early detection and improved prognoses. Treatment is managed by gynecologic oncologists, and often involves a combination of surgery, chemotherapy, and possible radiation treatments. Survivor care is managed by the primary-care clinician: expert attention to the mental, physical, and sexual health of each patient will ensure the best outcomes and quality of life.
在美国，每年约有 96,000 名妇女患有卵巢癌、子宫癌和阴道外阴癌，每年约有 29,000 人死亡。常规筛查方案无法检测到这些恶性肿瘤；因此，识别危险因素和评估令人担忧的症状对于早期发现和改善预后至关重要。治疗由妇科肿瘤学家管理，通常涉及手术、化疗和可能的放射治疗。生存者护理由初级保健临床医生管理：对每位患者的心理、身体和性健康给予专家关注，将确保最佳的结果和生活质量。
Zotero 插件